Turn Therapeutics Inc (TTRX)

Currency in USD
9.60
-0.81(-7.78%)
Closed·
9.79+0.19(+1.98%)
·
Advertisement
TTRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.5710.50
52 wk Range
2.5726.50
Key Statistics
Prev. Close
10.41
Open
10.5
Day's Range
9.57-10.5
52 wk Range
2.57-26.5
Volume
19.78K
Average Volume (3m)
80.97K
1-Year Change
-
Book Value / Share
0.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TTRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
26.00
Upside
+170.83%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Turn Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 26.00
(+170.83% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Ladenburg Thalmann
Buy26.00+170.83%-New Coverage20/07/2026

Earnings

Latest Release
11/05/2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare TTRX to Peers and Sector

Metrics to compare
TTRX
Peers
Sector
Relationship
P/E Ratio
−74.5x71.3x−0.4x
PEG Ratio
0.720.090.00
Price/Book
46.7x3.5x2.6x
Price / LTM Sales
-3.9x3.1x
Upside (Analyst Target)
149.8%−15.0%48.2%
Fair Value Upside
Unlock3.8%5.8%Unlock

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
140.79K0.47%1.47M
Other Institutional Investors
2.17M7.29%22.61M
Public Companies & Retail Investors
27.48M92.24%286.02M
Total
29.79M100.00%310.09M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Anc Carlson Family LP4.86%1,447,26815,066
SteelPeak Wealth, LLC0.84%249,4562,597

People Also Watch

2.87
CRE
+8.29%
5.60
INLF
+24.17%

FAQ

What Is the Turn Therapeutics (NASDAQ: TTRX) Share Price Today?

The Turn Therapeutics stock price today is 9.60 USD.

What Stock Exchange Does Turn Therapeutics (TTRX) Trade On?

Turn Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Turn Therapeutics?

The stock symbol (also called a 'ticker') for Turn Therapeutics is "TTRX."

What Is the Current Turn Therapeutics Market Capitalisation?

As of today, Turn Therapeutics (NASDAQ: TTRX) market cap is 285.97M USD.

What Is Turn Therapeutics's (TTRX) Earnings Per Share (TTM)?

The Turn Therapeutics EPS is currently -0.14 (Trailing Twelve Months).

When Is the Next Turn Therapeutics Earnings Date?

Turn Therapeutics's next earnings report will be released on 02/09/2026.

Is TTRX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Turn Therapeutics moving averages and other technical indicators, the daily buy/sell signal for TTRX stock is Strong Buy.

How Many Times Has Turn Therapeutics Stock Split?

Turn Therapeutics has split 0 times. (See the TTRX stock split history page for full effective split date and price information.)

What is the current trading status of Turn Therapeutics (NASDAQ: TTRX)?

As of 11/08/2026, Turn Therapeutics (TTRX) is trading at a share price of 9.60 USD, with a previous close of 10.41 USD. The stock has fluctuated within a day range of 9.57 USD to 10.50 USD, while its 52-week range spans from 2.57 USD to 26.50 USD.

What Is Turn Therapeutics (TTRX) Price Target According to Analysts?

The average 12-month price target for Turn Therapeutics is 26.00 USD, with a high estimate of 26 USD and a low estimate of 26 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +170.83% Upside potential.

What Is the TTRX Premarket Price?

TTRX's last pre-market stock price is 10.23 USD. The pre-market share volume is 50.00, and the stock has decreased by -0.18, or -1.73%.

What Is the TTRX After Hours Price?

TTRX's last after hours stock price is 9.79 USD, the stock has decreased by 0.19, or 1.98%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.